학술논문

Safety of omitting routine bleeding tests prior to image-guided musculoskeletal core needle biopsy
Scientific Article
Document Type
Academic Journal
Source
Skeletal Radiology. February 2018, Vol. 47 Issue 2, p215, 7 p.
Subject
Comparative analysis
Safety and security measures
Clopidogrel -- Safety and security measures -- Comparative analysis
Liver -- Comparative analysis -- Safety and security measures
Language
English
ISSN
0364-2348
Abstract
Author(s): Yuri Shif [sup.1], Justin W. Kung [sup.1], Colm J. McMahon [sup.1], Jennifer Ni Mhuircheartaigh [sup.1], Yu Ching Lin [sup.1] [sup.2], Megan E. Anderson [sup.3], Jim S. Wu [sup.1] Author [...]
Purpose To evaluate the safety of withholding preprocedure international normalized ratio (INR) and platelet testing in patients undergoing musculoskeletal (MSK) core needle biopsy (CNB). Material and methods Initially, a retrospective review of 1,162 consecutive patients undergoing MSK CNB with preprocedural INR and platelet testing was performed. Clinical (age, gender, bleeding disorder, liver disease, anticoagulation use, INR > 2, platelet count Results In the first phase, there was a complication rate of 2.6%, 30/1162. Of the 11 clinical and biopsy factors, soft tissue lesions (p = 0.029) and lesions biopsied under ultrasound (p = 0.048) had a higher rate of bleeding than bone lesions or lesions biopsied under CT, respectively. Only three patients had an INR >2, 0.3% (3/1162) and only four patients had platelet count Conclusion Bleeding complications from MSK biopsy are low, even when preprocedure coagulation testing is omitted.